Notice of Application to Vary the Conditions of a Registered Trade Name Product (Notice No. MPI 588)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following variation application has been made to a registered trade name product under section 9(2) of the Act:
Trade Name: Baytril 10% Injectable Solution
Reference: A5581
Active Ingredient and Concentration:
Enrofloxacin 100mg
Formulation Type: Aqueous solution
General Use Claim:
Anti-infective agent for the therapy of diseases caused by bacteria. For intravenous and subcutaneous injection in cattle and intramuscular injection in pigs.
Proposed Variation to Conditions:
Peracute/acute mastitis in lactating cows caused by susceptible E. coli.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Bayer New Zealand Limited, 3 Argus Place, Hillcrest, Auckland 0627. Postal Address: PO Box 2825, Shortland Street, Auckland 1140.
Dated at Wellington this 12th day of January 2016.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).